- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.77 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXG: 1-benzyl-1H-imidazo[4,5-b]pyridine(Non-covalent)
- 72 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: S.121, K.122
Ligand excluded by PLIPSO4.3: 6 residues within 4Å:- Chain A: G.9, T.10, K.42, R.88
- Ligands: EXG.1, DMS.6
Ligand excluded by PLIPSO4.4: 5 residues within 4Å:- Chain A: H.18, R.91, S.128, S.129
- Ligands: DMS.6
Ligand excluded by PLIPSO4.5: 6 residues within 4Å:- Chain A: S.39, P.40, S.41
- Chain F: E.134, H.138
- Ligands: EXG.1
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain B: S.121, K.122
Ligand excluded by PLIPSO4.9: 6 residues within 4Å:- Chain B: G.9, T.10, K.42, R.88
- Ligands: EXG.7, DMS.12
Ligand excluded by PLIPSO4.10: 5 residues within 4Å:- Chain B: H.18, R.91, S.128, S.129
- Ligands: DMS.12
Ligand excluded by PLIPSO4.11: 6 residues within 4Å:- Chain B: S.39, P.40, S.41
- Chain H: E.134, H.138
- Ligands: EXG.7
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain C: S.121, K.122
Ligand excluded by PLIPSO4.15: 6 residues within 4Å:- Chain C: G.9, T.10, K.42, R.88
- Ligands: EXG.13, DMS.18
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain C: H.18, R.91, S.128, S.129
- Ligands: DMS.18
Ligand excluded by PLIPSO4.17: 6 residues within 4Å:- Chain C: S.39, P.40, S.41
- Chain G: E.134, H.138
- Ligands: EXG.13
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain D: S.121, K.122
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain D: G.9, T.10, K.42, R.88
- Ligands: EXG.19, DMS.24
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain D: H.18, R.91, S.128, S.129
- Ligands: DMS.24
Ligand excluded by PLIPSO4.23: 6 residues within 4Å:- Chain D: S.39, P.40, S.41
- Chain E: E.134, H.138
- Ligands: EXG.19
Ligand excluded by PLIPSO4.26: 2 residues within 4Å:- Chain E: S.121, K.122
Ligand excluded by PLIPSO4.27: 6 residues within 4Å:- Chain E: G.9, T.10, K.42, R.88
- Ligands: EXG.25, DMS.30
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain E: H.18, R.91, S.128, S.129
- Ligands: DMS.30
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain E: S.39, P.40, S.41
- Chain J: E.134, H.138
- Ligands: EXG.25
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain F: S.121, K.122
Ligand excluded by PLIPSO4.33: 6 residues within 4Å:- Chain F: G.9, T.10, K.42, R.88
- Ligands: EXG.31, DMS.36
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain F: H.18, R.91, S.128, S.129
- Ligands: DMS.36
Ligand excluded by PLIPSO4.35: 6 residues within 4Å:- Chain F: S.39, P.40, S.41
- Chain L: E.134, H.138
- Ligands: EXG.31
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain G: S.121, K.122
Ligand excluded by PLIPSO4.39: 6 residues within 4Å:- Chain G: G.9, T.10, K.42, R.88
- Ligands: EXG.37, DMS.42
Ligand excluded by PLIPSO4.40: 5 residues within 4Å:- Chain G: H.18, R.91, S.128, S.129
- Ligands: DMS.42
Ligand excluded by PLIPSO4.41: 6 residues within 4Å:- Chain G: S.39, P.40, S.41
- Chain K: E.134, H.138
- Ligands: EXG.37
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain H: S.121, K.122
Ligand excluded by PLIPSO4.45: 6 residues within 4Å:- Chain H: G.9, T.10, K.42, R.88
- Ligands: EXG.43, DMS.48
Ligand excluded by PLIPSO4.46: 5 residues within 4Å:- Chain H: H.18, R.91, S.128, S.129
- Ligands: DMS.48
Ligand excluded by PLIPSO4.47: 6 residues within 4Å:- Chain H: S.39, P.40, S.41
- Chain I: E.134, H.138
- Ligands: EXG.43
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain I: S.121, K.122
Ligand excluded by PLIPSO4.51: 6 residues within 4Å:- Chain I: G.9, T.10, K.42, R.88
- Ligands: EXG.49, DMS.54
Ligand excluded by PLIPSO4.52: 5 residues within 4Å:- Chain I: H.18, R.91, S.128, S.129
- Ligands: DMS.54
Ligand excluded by PLIPSO4.53: 6 residues within 4Å:- Chain B: E.134, H.138
- Chain I: S.39, P.40, S.41
- Ligands: EXG.49
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain J: S.121, K.122
Ligand excluded by PLIPSO4.57: 6 residues within 4Å:- Chain J: G.9, T.10, K.42, R.88
- Ligands: EXG.55, DMS.60
Ligand excluded by PLIPSO4.58: 5 residues within 4Å:- Chain J: H.18, R.91, S.128, S.129
- Ligands: DMS.60
Ligand excluded by PLIPSO4.59: 6 residues within 4Å:- Chain D: E.134, H.138
- Chain J: S.39, P.40, S.41
- Ligands: EXG.55
Ligand excluded by PLIPSO4.62: 2 residues within 4Å:- Chain K: S.121, K.122
Ligand excluded by PLIPSO4.63: 6 residues within 4Å:- Chain K: G.9, T.10, K.42, R.88
- Ligands: EXG.61, DMS.66
Ligand excluded by PLIPSO4.64: 5 residues within 4Å:- Chain K: H.18, R.91, S.128, S.129
- Ligands: DMS.66
Ligand excluded by PLIPSO4.65: 6 residues within 4Å:- Chain C: E.134, H.138
- Chain K: S.39, P.40, S.41
- Ligands: EXG.61
Ligand excluded by PLIPSO4.68: 2 residues within 4Å:- Chain L: S.121, K.122
Ligand excluded by PLIPSO4.69: 6 residues within 4Å:- Chain L: G.9, T.10, K.42, R.88
- Ligands: EXG.67, DMS.72
Ligand excluded by PLIPSO4.70: 5 residues within 4Å:- Chain L: H.18, R.91, S.128, S.129
- Ligands: DMS.72
Ligand excluded by PLIPSO4.71: 6 residues within 4Å:- Chain A: E.134, H.138
- Chain L: S.39, P.40, S.41
- Ligands: EXG.67
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain M: S.121, K.122
Ligand excluded by PLIPSO4.75: 4 residues within 4Å:- Chain M: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.77: 2 residues within 4Å:- Chain N: S.121, K.122
Ligand excluded by PLIPSO4.78: 4 residues within 4Å:- Chain N: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.80: 2 residues within 4Å:- Chain O: S.121, K.122
Ligand excluded by PLIPSO4.81: 4 residues within 4Å:- Chain O: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.83: 2 residues within 4Å:- Chain P: S.121, K.122
Ligand excluded by PLIPSO4.84: 4 residues within 4Å:- Chain P: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.86: 2 residues within 4Å:- Chain Q: S.121, K.122
Ligand excluded by PLIPSO4.87: 4 residues within 4Å:- Chain Q: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.89: 2 residues within 4Å:- Chain R: S.121, K.122
Ligand excluded by PLIPSO4.90: 4 residues within 4Å:- Chain R: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.92: 2 residues within 4Å:- Chain S: S.121, K.122
Ligand excluded by PLIPSO4.93: 4 residues within 4Å:- Chain S: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.95: 2 residues within 4Å:- Chain T: S.121, K.122
Ligand excluded by PLIPSO4.96: 4 residues within 4Å:- Chain T: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.98: 2 residues within 4Å:- Chain U: S.121, K.122
Ligand excluded by PLIPSO4.99: 4 residues within 4Å:- Chain U: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.101: 2 residues within 4Å:- Chain V: S.121, K.122
Ligand excluded by PLIPSO4.102: 4 residues within 4Å:- Chain V: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.104: 2 residues within 4Å:- Chain W: S.121, K.122
Ligand excluded by PLIPSO4.105: 4 residues within 4Å:- Chain W: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.107: 2 residues within 4Å:- Chain X: S.121, K.122
Ligand excluded by PLIPSO4.108: 4 residues within 4Å:- Chain X: H.18, R.91, S.128, S.129
Ligand excluded by PLIP- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.6: 6 residues within 4Å:- Chain A: Y.7, P.8, R.88, G.89
- Ligands: SO4.3, SO4.4
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.7, A:G.89
- Salt bridges: A:E.99
DMS.12: 6 residues within 4Å:- Chain B: Y.7, P.8, R.88, G.89
- Ligands: SO4.9, SO4.10
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Y.7, B:G.89
- Salt bridges: B:E.99
DMS.18: 6 residues within 4Å:- Chain C: Y.7, P.8, R.88, G.89
- Ligands: SO4.15, SO4.16
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:G.89
- Salt bridges: C:E.99
DMS.24: 6 residues within 4Å:- Chain D: Y.7, P.8, R.88, G.89
- Ligands: SO4.21, SO4.22
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:G.89
- Salt bridges: D:E.99
DMS.30: 6 residues within 4Å:- Chain E: Y.7, P.8, R.88, G.89
- Ligands: SO4.27, SO4.28
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:Y.7, E:G.89
- Salt bridges: E:E.99
DMS.36: 6 residues within 4Å:- Chain F: Y.7, P.8, R.88, G.89
- Ligands: SO4.33, SO4.34
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:G.89
- Salt bridges: F:E.99
DMS.42: 6 residues within 4Å:- Chain G: Y.7, P.8, R.88, G.89
- Ligands: SO4.39, SO4.40
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:Y.7, G:G.89
- Salt bridges: G:E.99
DMS.48: 6 residues within 4Å:- Chain H: Y.7, P.8, R.88, G.89
- Ligands: SO4.45, SO4.46
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:G.89
- Salt bridges: H:E.99
DMS.54: 6 residues within 4Å:- Chain I: Y.7, P.8, R.88, G.89
- Ligands: SO4.51, SO4.52
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:G.89
- Salt bridges: I:E.99
DMS.60: 6 residues within 4Å:- Chain J: Y.7, P.8, R.88, G.89
- Ligands: SO4.57, SO4.58
3 PLIP interactions:3 interactions with chain J- Hydrogen bonds: J:Y.7, J:G.89
- Salt bridges: J:E.99
DMS.66: 6 residues within 4Å:- Chain K: Y.7, P.8, R.88, G.89
- Ligands: SO4.63, SO4.64
3 PLIP interactions:3 interactions with chain K- Hydrogen bonds: K:Y.7, K:G.89
- Salt bridges: K:E.99
DMS.72: 6 residues within 4Å:- Chain L: Y.7, P.8, R.88, G.89
- Ligands: SO4.69, SO4.70
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:G.89
- Salt bridges: L:E.99
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moreau, R.J. et al., Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria. J. Med. Chem. (2018)
- Release Date
- 2018-03-14
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
BN
BO
BP
BQ
BR
BS
BT
BU
BV
BW
BX
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.77 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x EXG: 1-benzyl-1H-imidazo[4,5-b]pyridine(Non-covalent)
- 72 x SO4: SULFATE ION(Non-functional Binders)
- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Moreau, R.J. et al., Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria. J. Med. Chem. (2018)
- Release Date
- 2018-03-14
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
BN
BO
BP
BQ
BR
BS
BT
BU
BV
BW
BX
B